PubMed:21421994 / 294-406
Annnotations
GlycoBiology-FMA
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| _T19 | 62-72 | FMAID:167180 | denotes | antibodies |
GlycoBiology-NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 51-61 | http://purl.bioontology.org/ontology/NCBITAXON/608684 | denotes | monoclonal |
GO-MF
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2 | 62-72 | http://purl.obolibrary.org/obo/GO_0003823 | denotes | antibodies |
Allie
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| SS1_21421994_2_0 | 51-72 | expanded | denotes | monoclonal antibodies |
| SS2_21421994_2_0 | 74-78 | abbr | denotes | Mabs |
| AE1_21421994_2_0 | SS1_21421994_2_0 | SS2_21421994_2_0 | abbreviatedTo | monoclonal antibodies,Mabs |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T3 | 0-112 | Sentence | denotes | Clearance is of obvious importance for therapeutic monoclonal antibodies (Mabs) as it directly impacts efficacy. |
| T3 | 0-112 | Sentence | denotes | Clearance is of obvious importance for therapeutic monoclonal antibodies (Mabs) as it directly impacts efficacy. |
| T3 | 0-112 | Sentence | denotes | Clearance is of obvious importance for therapeutic monoclonal antibodies (Mabs) as it directly impacts efficacy. |